Gadolinium(III) complex equilibria: the implications for Gd(III) MRI contrast agents.

Area of Science:

• Biophysical Chemistry
• Computational Biology
• Pharmacology

Background:

• Gadolinium (Gd(III)) contrast agents are widely used in medical imaging.
• Understanding their behavior in blood plasma is crucial for assessing safety and efficacy.
• Existing models may not fully capture the complex interactions of Gd(III) with plasma components.

Purpose of the Study:

• To develop a computational model simulating Gd(III) contrast agent interactions in blood plasma.
• To predict the binding and distribution of Gd(III) with various plasma ligands.
• To investigate the relationship between complex stability, kinetics, and the toxicity of Gd(III) species.

Main Methods:

• Development of a computer model for blood plasma.
• Simulation of Gd(III) binding to plasma proteins (transferrin) and small molecules (citrate, salicylate).
• Analysis of Gd(III) interactions with chelating agents like EDTA and DTPA at varying concentrations.

Main Results:

• Gd(III) initially binds to transferrin, then to citrate and salicylate at higher concentrations.
• GdCl3 at 10(-3) M alters the distribution of Zn(II), Ca(II), and Fe(II) in plasma, with minimal effect on Cu(II).
• EDTA and DTPA effectively chelate Gd(III) above 10(-5) M, reducing free Gd(III) concentration.

Conclusions:

• The model provides insights into Gd(III) behavior and metal ion redistribution in blood plasma.
• Thermodynamic stability and substitution kinetics are important factors in Gd(III) complex toxicity.
• This simulation approach can inform the development of safer contrast agents.